Distinguished in TNF Receptor-Associated Periodic Syndrome

Mauro Galeazzi

Siena, IT 
Distinguished in TNF Receptor-Associated Periodic Syndrome
Siena, IT 
OverviewLocationsClinical Research

Overview

Mauro Galeazzi practices in Siena, Italy. Mr. Galeazzi is rated as a Distinguished expert by MediFind in the treatment of TNF Receptor-Associated Periodic Syndrome. His top areas of expertise are Arthritis, Uveitis, Ochronosis, and Rheumatoid Arthritis (RA).

His clinical research consists of co-authoring 230 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 11 articles in the study of TNF Receptor-Associated Periodic Syndrome.

Gender
Male

Locations

Siena, Italy
Other Locations
Rome, Italy
Italy
Padova, Italy
Milan, Italy
Viale, 53100, Italy
Le Scotte, 53100, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate Safety and Clinical Efficacy of Two Different Doses of F8IL10 (Dekavil) Administered Subcutaneously to Patients With Active Rheumatoid Arthritis Receiving Methotrexate.
Enrollment Status: Terminated
Publish Date: June 12, 2023
Intervention Type: Drug
Study Drugs: F8IL10, Methotrexate
Study Phase: Phase 2
A Dose-finding, Pharmacokinetic Phase I Study of the Human Monoclonal Antibody-cytokine Fusion Protein F8IL10 (Dekavil) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
A Dose-finding, Pharmacokinetic Phase I Study of the Human Monoclonal Antibody-cytokine Fusion Protein F8IL10 (Dekavil) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: May 18, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

230 Total Publications

The scar: the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias.
The scar: the wind in the perfect storm-insights into the mysterious living tissue originating ventricular arrhythmias.
Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
Published: January 15, 2021

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Galeazzi's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 13 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile